Asadorian Raffi's most recent trade in Talphera Inc. was a trade of 2,444 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on April 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.72 per share. | 02 Apr 2026 | 2,444 | 85,879 (0%) | 0% | 0.7 | 1,765 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 260,000 | 260,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 10 Feb 2026 | 45,000 | 91,256 (0%) | 0% | 0.8 | 36,554 | Commom Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.79 per share. | 10 Feb 2026 | 2,933 | 88,323 (0%) | 0% | 0.8 | 2,327 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.84 per share. | 10 Feb 2026 | 958 | 46,256 (0%) | 0% | 0.8 | 801 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 15,000 | 47,214 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 14 Feb 2025 | 3,245 | 32,214 (0%) | 0% | 0.7 | 2,174 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 10 Feb 2025 | 1,060 | 35,459 (0%) | 0% | 0.6 | 657 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. | 10 Feb 2025 | 1,059 | 36,519 (0%) | 0% | 0.6 | 667 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.77 per share. | 02 Dec 2024 | 155 | 37,578 (0%) | 0% | 0.8 | 119 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 03 Mar 2024 | 558 | 37,733 (0%) | 0% | 1.3 | 725 | Common Stock |
| Talphera Inc | Asadorian Raffi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 108,000 | 108,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc | Asadorian Raffi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 18,000 | 38,291 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 10 Feb 2024 | 895 | 20,291 (0%) | 0% | 1.1 | 985 | Common Stock |
| Talphera Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 10 Feb 2024 | 895 | 21,186 (0%) | 0% | 1.1 | 985 | Common Stock |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.31 per share. | 03 Mar 2023 | 510 | 22,081 (0%) | 0% | 1.3 | 668 | Common Stock |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 35,250 | 35,250 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 5,875 | 23,464 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. | 10 Feb 2023 | 873 | 22,591 (0%) | 0% | 1.7 | 1,467 | Common Stock |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. | 06 Feb 2023 | 617 | 17,589 (0%) | 0% | 2.0 | 1,246 | Common Stock |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 03 Mar 2022 | 7,923 | 364,205 (0%) | 0% | 0.4 | 3,223 | Common Stock |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 117,500 | 376,015 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. | 11 Feb 2022 | 7,927 | 368,080 (0%) | 0% | 0.4 | 3,182 | Common Stock |
| Acelrx Pharma Inc | Raffi Asadorian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 06 Feb 2022 | 9,391 | 258,515 (0%) | 0% | 0.4 | 4,049 | Common Stock |